United States - English - NLM (National Library of Medicine)

durvet, inc. - ivermectin (unii: 8883yp2r6d) (ivermectin - unii:8883yp2r6d) - ivermectin 5 mg in 5 l - indications ivermectin (ivermectin topical solution) pour-on applied at the recommended dose level of 500 mcg/kg is indicated for the effective treatment and control of these parasites. gastrointestinal roundworms ostertagia ostertagi                (adults and l4 ) (including inhibited state) haemonchus placei                (adults and l4 ) trichostrongylus axei              (adults and l4 ) t. colubriformis                      (adults and l4 ) cooperia oncophora                (adults and l4 ) cooperia punctata                  (adults and l4 ) cooperia surnabada                (adults and l4 ) strongyloides papillosus         (adults) oesophagostomum radiatum   (adults and l4 ) trichuris spp.                         (adults) lungworms dictyocaulus viviparus             (adults and l4 ) cattle grubs                         (parasitic stages) hypoderma bovis h. lineatum mites sarcoptes scabiei var. bovis lice linognathus vituli haematopinus eurysternus damalinia bovis solenopotes capillatus horn flies haem

United States - English - NLM (National Library of Medicine)

durvet - ivermectin (unii: 8883yp2r6d) (ivermectin - unii:8883yp2r6d) - ivermectin 5 mg in 1 ml - ivermectin pour-on for cattle applied at the recommended dose level of 500 mcg/kg is indicated for the effective treatment and control of these parasites. gastrointestinal roundworms ostertagia ostertagi (including inhibited stage)        (adults and l4 ) haemonchus placei                                                 (adults and l4 ) trichostrongylus axei                                              (adults and l4 ) t. colubriformis                                                       (adults and l4 ) cooperia oncophora                                                 (adults and l4 ) cooperia punctata                                                  (adults and l4 ) cooperia surnabada                                                 (adults and l4 ) strongyloides papillosus                                                      (adults) oesophagostomum radiatum                                  (adults and l4 ) trichuris spp.                                                                    (adults) lungworms dictyocaulus viviparus                                              (adults and l4 ) cattle grubs                                                       (parasitic stages) hypoderma bovis h. lineatum mites sarcoptes scabiei var. bovis lice linognathus vituli haematopinus eurystemus damalinia bovis solenopotes capillatus horn flies haematobia irritans persistent activity ivermectin pour-on for cattle has been proved to effectively control infections and to protect cattle from re-infection with: oesophagostomum radiatum and dictyocaulus viviparous for 28 days after treatment; cooperia punctata and trichostrongylus axei for 21 days after treatment; ostertagia ostertagi , haemonchus placei , cooperia oncophora and cooperia surnabada for 14 days after treatment; damalinia bovis for 56 days after treatment. treatment of cattle for horn flies ivermectin pour-on for cattle controls horn flies (haematobia irritans ) for up to 28 days after dosing. for best results ivermectin pour-on for cattle should be part of a parasite control program for both internal and external parasites based on the epidemiology of these parasites. consult your veterinarian or an entomologist for the most effective timing of applications. manufactured for: durvet inc. blue springs, missouri 64014 www.durvet.com

United States - English - NLM (National Library of Medicine)

viona pharmaceuticals inc - ivermectin (unii: 8883yp2r6d) (ivermectin - unii:8883yp2r6d) - ivermectin cream is indicated for the treatment of inflammatory lesions of rosacea. none. there are no adequate and well-controlled studies in pregnant women. ivermectin cream should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. note: the animal multiples of human exposure calculations were based on auc comparisons. the maximum topical human dose (mthd) of ivermectin cream is 1 g applied once daily. risk summary the available data on the use of ivermectin, including ivermectin cream, in pregnant women are insufficient to establish a drug- associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. in animal reproduction studies, ivermectin induced adverse developmental outcomes when orally administered to pregnant rats and rabbits during the period of organogenesis at doses 1909 or 354 times the maximum recommended human dose (mrhd), respectively. these orally administered doses were maternally toxic to pregnant rats and rabbi

United States - English - NLM (National Library of Medicine)

durvet, inc. - ivermectin (unii: 8883yp2r6d) (ivermectin - unii:8883yp2r6d) - ivermectin 5 mg in 1 ml - ivermectin pour-on (ivermectin topical solution) applied at the recommended dose level of 500 mcg/kg is indicated for the effective control of these parasites. gastrointestinal roundworms mites sarcoptes scabiei var. bovis lice linognathus vituli haematopinus eurysternus damalinia bovis solenopotes capillatus horn flies haematobia irritans

United States - English - NLM (National Library of Medicine)

durvet - ivermectin (unii: 8883yp2r6d) (ivermectin - unii:8883yp2r6d) - ivermectin 10 mg in 1 ml - indications cattle : ivermectin injection is indicated for the effective treatment and control of the following harmful species of gastrointestinal roundworms, lungworms, grubs, sucking lice, and mange mites in cattle. gastrointestinal roundworms (adults and fourth-stage larvae): ostertagia ostertagi (including inhibited o. ostertagi ) o. lyrata haemonchus placei trichostrongylus axei t. colubriformis cooperia oncophora c. punctata c. pectinata oesophagostomum radiatum bunostomum phlebotomum nematodirus helvetianus (adults only) n. spathiger (adults only) lungworms (adults and fourth stage larvae): dictyocaulus viviparus cattle grubs (parasitic stages): hypoderma bovis h. lineatum sucking lice : linognathus vituli haematopinus eurysternus solenopotes capillatus mites (scabies): psoroptes ovis (syn. p. communis var. bovis ) sarcoptes scabiei var. bovis persistent activity ivermectin injection has been proved to effectively control infections and to protect cattle from reinfection with dictyocaulus v

United States - English - NLM (National Library of Medicine)

jeffers - ivermectin (unii: 8883yp2r6d) (ivermectin - unii:8883yp2r6d) - ivermectin 18.7 mg in 1 g - indications : consult your veterinarian for assistance in the diagnosis, treatment, and control of parasitism. ivermectin (ivermectin paste) provides effective treatment and control of the following parasites in horses. large strongyles (adults)- strongylus vulgaris (also early forms in blood vessels), s. edentatus (also tissue stages), s. equinus , triodontophorus spp. including t. brevicauda and t. serratus and craterostomum acuticaudatum ; small strongyles (adults, including those resistant to some benzimidazole class compounds)-coronocyclus spp. including c. coronatus , c. labiatus and c. labratus, cyathostomum spp. including c. catinatum and c. pateratum, cylicocyclus spp. including c. insigne , c. leptostomum, c. nassatus , and c. brevicapsulatus, cylicodontophorus spp., cylicostephanus spp. including c. calicatus, c. goldi, c. longibursatus and c. minutus, and petrovinema poculatum ; small strongyles - fourth-stage larvae; pinworms (adults and fourth-stage larvae)-oxyuris equi ; ascar

United States - English - NLM (National Library of Medicine)

durvet - ivermectin (unii: 8883yp2r6d) (ivermectin - unii:8883yp2r6d) - ivermectin 18.7 mg in 1 g - indications : consult your veterinarian for assistance in the diagnosis, treatment, and control of parasitism. ivermectin (ivermectin paste) provides effective treatment and control of the following parasites in horses. large strongyles (adults)- strongylus vulgaris (also early forms in blood vessels), s. edentatus (also tissue stages), s. equinus , triodontophorus spp. including t. brevicauda and t. serratus and craterostomum acuticaudatum ; small strongyles (adults, including those resistant to some benzimidazole class compounds)-coronocyclus spp. including c. coronatus , c. labiatus and c. labratus, cyathostomum spp. including c. catinatum and c. pateratum, cylicocyclus spp. including c. insigne , c. leptostomum, c. nassatus , and c. brevicapsulatus, cylicodontophorus spp., cylicostephanus spp. including c. calicatus, c. goldi, c. longibursatus and c. minutus, and petrovinema poculatum ; small strongyles - fourth-stage larvae; pinworms (adults and fourth-stage larvae)-oxyuris equi ; ascar

United States - English - NLM (National Library of Medicine)

prasco laboratories - ivermectin (unii: 8883yp2r6d) (ivermectin - unii:8883yp2r6d) - ivermectin cream is indicated for the treatment of inflammatory lesions of rosacea. none. pregnancy category c. there are no adequate and well-controlled studies in pregnant women. ivermectin cream should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. note: the animal multiples of human exposure calculations were based on auc comparisons. the maximum topical human dose (mthd) of ivermectin cream is 1 g applied once daily. systemic embryofetal development studies were conducted in rats and rabbits. oral doses of 1.5, 4, and 12 mg/kg/day ivermectin were administered during the period of organogenesis (gestational days 6–17) to pregnant female rats. maternal death occurred at 12 mg/kg/day (1909x mthd). cleft palate occurred in the fetuses from the 12 mg/kg/day (1909x mthd) group. no treatment related effects on embryofetal toxicity or teratogenicity were noted at 4 mg/kg/day (708x mthd). oral doses of 0.5, 1.5, 2.5, 3.5 and 4.5 mg/kg/day ivermectin were admin

United States - English - NLM (National Library of Medicine)

taro pharmaceuticals u.s.a., inc. - ivermectin (unii: 8883yp2r6d) (ivermectin - unii:8883yp2r6d) - ivermectin lotion is indicated for the topical treatment of head lice infestations in patients 6 months of age and older. ivermectin lotion should be used in the context of an overall lice management program: - wash (in hot water) or dry-clean all recently worn clothing, hats, used bedding and towels. - wash personal care items such as combs, brushes and hair clips in hot water. - a fine-tooth comb or special nit comb may be used to remove dead lice and nits. none. risk summary there are no studies with the use of ivermectin lotion in pregnant women. epidemiologic studies with the use of oral ivermectin during pregnancy are insufficient to inform a drug-associated risk of adverse developmental outcomes, because either the timing of administration during gestation was not accurately ascertained or the administration occurred only during the second trimester (see data) . however, systemic exposure from topical use of ivermectin is much lower than that from oral use [see clinical pharmacology (12.3)]. in animal

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - ivermectin (unii: 8883yp2r6d) (ivermectin - unii:8883yp2r6d) - ivermectin cream, 1% is indicated for the treatment of inflammatory lesions of rosacea. none. pregnancy category c. there are no adequate and well-controlled studies in pregnant women. ivermectin cream should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. note: the animal multiples of human exposure calculations were based on auc comparisons. the maximum topical human dose (mthd) of ivermectin cream is 1 g applied once daily. systemic embryofetal development studies were conducted in rats and rabbits. oral doses of 1.5 mg/kg/day, 4 mg/kg/day, and 12 mg/kg/day ivermectin were administered during the period of organogenesis (gestational days 6 to 17) to pregnant female rats. maternal death occurred at 12 mg/kg/day (1909x mthd). cleft palate occurred in the fetuses from the 12 mg/kg/day (1909x mthd) group. no treatment related effects on embryofetal toxicity or teratogenicity were noted at 4 mg/kg/day (708x mthd). oral doses of 0.5 mg/kg/day, 1.5 mg/kg/day, 2.5